A pair of San Antonio biotech companies, BioBridge Global and StemBioSys Inc., have agreed to expand the scope of their collaborative relationship in an effort to bring a new source of stem cells to the research market.
Recent Posts
- Engineered Dendritic Cells Harness Tumor EVs to Boost Cancer Immunotherapy
- Top FDA Gene and Cell Therapy News: 2025 Year-End Recap
- Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy
- The 98% mystery: Scientists just cracked the code on “junk DNA” linked to Alzheimer’s
- New method preserves iPS cells for regenerative medicine
- MIT Scientists Have Discovered a Way To Rejuvenate the Immune System

